CANF SBC to Revenue

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · SBC to Revenue

CANF SBC to Revenue

Current (TTM)44.69%retrievedOct 20, 2026

CANF SBC/Revenue (23.75% → 44.69%)

Latest values, visible window

Share image ↗High-resolution chart · PNG

CANF sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares SBC to Revenue — Annual fiscal periods

Period ending	SBC to Revenue
Dec 31, 2025	77.5547%
Dec 31, 2024	53.7092%
Dec 31, 2023	35.1279%
Dec 31, 2022	32.4691%
Dec 31, 2021	54.6307%
Dec 31, 2020	46.5269%
Dec 31, 2019	18.9469%
Dec 31, 2018	14.0052%
Dec 31, 2017	23.0926%
Dec 31, 2016	182.3009%
Dec 31, 2015	66.1741%
Dec 31, 2014	0%
Dec 31, 2013	0%
Dec 31, 2012	0%
Dec 31, 2011	17.8712%
Dec 31, 2010	23.7517%